The NEOMED Institute

Pioneering the bridge between basic research and drug development through public-private partnerships in the pharma industry.

Founded 2011 4 employees Venture round Total: $45.70M Biotechnology, Life Sciences +1

Neomed Institute is a not-for-profit organization that was established in 2011, with a focus on pioneering the bridge between basic research and drug development within the Biotechnology and Pharmaceutical industries. The company's slogan "Pioneering the bridge between basic research and drug development through public-private partnerships in the pharma industry" encapsulates its mission. NEOMED operates through a public-private partnership with the government and biopharmaceutical companies. Its innovative approach aims to address the changing pharma R&D landscape by bridging the considerable gap between basic research and later-stage drug development. Through the provision of expertise and $8.70M in debt financing investment at 08 July 2019 by Investissement Québec, NEOMED supports academic labs and early-stage biotechs in advancing emerging therapeutic approaches to the human proof of concept stage. This strategic approach significantly increases the value of these initiatives for NEOMED's downstream partners. NEOMED's unique model and strategic partnerships position the organization as a valuable player in advancing drug development and fostering collaboration between public and private entities, ultimately contributing to the advancement of innovative therapeutic solutions.

Funding Stage	Amount	Investors	Lead Investors	Date
Debt Financing	$8.70M	1	Investissement Québec	08 Jul 2019
Venture Round	$25.00M	3	adMare BioInnovations, Economic Development of Canada +1	08 Jul 2019
Grant	$12.00M	1	Government of Canada	25 Aug 2014

Funding Stage

Amount

Investors

Lead Investors

Date

Debt Financing

$8.70M

Investissement Québec

08 Jul 2019

Venture Round

$25.00M

adMare BioInnovations, Economic Development of Canada +1

08 Jul 2019

Grant

$12.00M

Government of Canada

25 Aug 2014

FAQ About The NEOMED Institute

Pioneering the bridge between basic research and drug development through public-private partnerships in the pharma industry.

The NEOMED Institute was founded in 2011.

The NEOMED Institute operates in Biotechnology, Life Sciences and Pharmaceutical. Its work centres on pharma industry, drug development, public-private partnerships and biopharmaceutical companies.

The NEOMED Institute has approximately 4 employees.

The NEOMED Institute has completed 3 funding rounds, raising a total of $45.70M. The latest funding stage is Venture round.

Top alternatives and competitors to The NEOMED Institute include BioHub, BioTReC, Sinica Academia , Complegen Inc, BioCurate Pty Ltd, ImmunGene, Prothya Biosolutions. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

The NEOMED Institute and BioHub, BioTReC, Sinica Academia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About The NEOMED Institute

Funding Rounds & Investors (3)

The NEOMED Institute Alternatives & Competitors

FAQ About The NEOMED Institute